Mild Cognitive Impairment in Relation to Alzheimer’s Disease: An Investigation of Principles, Classifications, Ethics, and Problems

Abstract Mild Cognitive Impairment (MCI) is a diagnostic category indicating cognitive impairment which does not meet criteria for dementia such as Alzheimer’s disease. There are public health concerns about disease (AD) prompting intervention strategies to respond predictions the impacts of ageing populations and decline. This relationship between MCI AD rests on three interrelated principles, namely, that exists MCI, progresses AD, there reliable system classification MCI. However, also several ethical issues problems arising in AD/MCI relationship. These include early diagnosis interventions, effects people with newer neuroimaging neuropharmacological approaches used treatment. All these pose questions principles relation implications how understood, diagnosed, treated, experienced by patients. article analyses four challenging areas neuroethics: definition MCI; AD; clinical disclosure, diagnosis, treatment; research The significant connections often overlooked, together uncertainties overall. Patients, healthcare systems society best served informed clinicians, academics researchers. After 35 years, store knowledge expanding evolving.